Literature DB >> 20425745

Stroke-like syndrome in a middle aged Nigerian woman with metastatic brain cancer.

M A Komolafe1, T A Sunmonu, O Oke.   

Abstract

BACKGROUND: Metastatic brain cancer constitutes about 24 to 25 % of brain tumours worldwide and in Nigeria it constitutes about 40% of brain tumors. The clinical presentation of metastatic tumors may be atypical.
OBJECTIVE: To present a middle aged Nigerian woman with a metastatic brain cancer who had a stroke-like syndrome.
METHODS: The patient was a 47-year old woman who presented with a two-week history of progressive weakness of the right upper and lower limbs, associated with headache, blurring of vision and slurring of speech. There was a history of weight loss but no history of cough or evening pyrexia. She was not a known hypertensive or diabetic patient though, there were positive history of diabetes mellitus in her father and elder senior brother. Her other systemic review and past medical history were not contributory.
RESULTS: Examination revealed a woman with expressive dysphasia and right spastic hemiparesis. Her pulse, blood pressure and heart sounds were normal. There was no carotid bruit. Imaging studies showed metastases in the brain, liver, chest, cervical lymph nodes and bone marrow. Cervical lymph node histology showed metastatic adenocarcinoma. She was managed with chemotherapy, steroids and other supportive therapy but she died on the 40th day of admission due to disease progression and aspiration pneumonitis.
CONCLUSION: Metastatic brain cancer may manifest atypically. Physicians should screen any patient with stroke without any apparent risk factors for possibilities of underlying metastatic brain cancer.

Entities:  

Mesh:

Year:  2009        PMID: 20425745

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  1 in total

Review 1.  Adult brain tumors in Sub-Saharan Africa: A scoping review.

Authors:  Ulrick Sidney Kanmounye; Claire Karekezi; Arsene Daniel Nyalundja; Ahmed K Awad; Tsegazeab Laeke; James A Balogun
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.